project-idea
Therapy-Related Leukemia Risk Calculator for Cancer Survivors
Therapy-related AML has tripled over 30 years as more cancer survivors live longer after genotoxic chemotherapy and radiation — yet patients and oncologists rarely have accessible tools to quantify this long-term risk when making treatment decisions or planning survivorship surveillance.